CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Carl Zeiss Meditec AG - AFX CFD

122.99
3.03%
0.52
最低: 122.94
最高: 128.18
Market Trading Hours* (UTC) Opens on Thursday at 07:00

Mon - Fri: 07:00 - 15:30

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.52
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.017913 %
Charges from borrowed part ($-0.72)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.017913%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.004309 %
Charges from borrowed part ($-0.17)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.004309%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 EUR
保证金 20%
上市交易所 Germany
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 126.83
开盘价* 128.18
1 年变化* -10.62%
日范围* 122.94 - 128.18
52 周范围 101.75-152.20
平均交易量(10 天) 129.20K
平均交易量(3 个月) 1.98M
市值 11.02B
市盈率 35.99
流通股 89.44M
收入 1.96B
EPS 3.42
股息(收益率 %) 0.89249
贝塔 0.66
下一个财报发布日期 May 9, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 29, 2023 122.99 -4.84 -3.79% 127.83 128.63 122.89
Mar 28, 2023 126.83 -8.14 -6.03% 134.97 135.52 126.83
Mar 27, 2023 134.47 1.70 1.28% 132.77 135.87 132.77
Mar 24, 2023 132.22 -3.90 -2.87% 136.12 136.17 131.77
Mar 23, 2023 134.77 3.85 2.94% 130.92 134.77 130.87
Mar 22, 2023 132.02 0.35 0.27% 131.67 133.82 131.02
Mar 21, 2023 131.27 -3.80 -2.81% 135.07 135.17 127.33
Mar 20, 2023 134.47 -2.25 -1.65% 136.72 138.66 134.37
Mar 17, 2023 137.51 0.20 0.15% 137.31 138.11 136.07
Mar 16, 2023 136.92 0.45 0.33% 136.47 137.07 132.67
Mar 15, 2023 135.07 -2.94 -2.13% 138.01 138.21 133.07
Mar 14, 2023 138.06 2.24 1.65% 135.82 140.16 135.62
Mar 13, 2023 135.77 0.30 0.22% 135.47 136.32 132.47
Mar 10, 2023 135.47 1.15 0.86% 134.32 136.07 134.17
Mar 9, 2023 136.37 3.65 2.75% 132.72 136.52 132.22
Mar 8, 2023 133.27 -0.20 -0.15% 133.47 134.42 132.32
Mar 7, 2023 134.82 -1.85 -1.35% 136.67 137.41 134.32
Mar 6, 2023 133.62 0.25 0.19% 133.37 134.12 132.47
Mar 3, 2023 133.52 0.85 0.64% 132.67 133.81 131.87
Mar 2, 2023 131.57 3.94 3.09% 127.63 131.97 127.43

Carl Zeiss Meditec AG Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 1902.84 1646.79 1335.45 1459.32 1280.86
收入 1902.84 1646.79 1335.45 1459.32 1280.86
收入成本,共计 775.238 679.572 589.935 627.437 570.471
毛利 1127.6 967.213 745.517 831.884 710.389
总营业费用 1505.96 1273.17 1157.9 1194.66 1083.73
销售/一般/行政费用,总计 438.06 363.98 349.161 393.913 353.646
研究与开发 291.365 232.066 218.804 173.312 159.628
营业收入 396.879 373.614 177.552 264.659 197.13
利息收入(费用),非经营净值 -44.479 -32.12 -21.351 -34.497 -20.449
其他,净值 51.089 -2.444 22.516 -0.304 2.502
税前净收入 403.489 339.05 178.717 229.858 179.183
税后净收入 295.911 237.519 123.421 160.579 126.23
少数股东权益 -2.002 -1.243 -1.036 -0.823 0.233
未计算非常项目前的净收益 293.909 236.276 122.385 159.756 126.463
净收入 293.909 236.276 122.385 159.756 126.463
普通股股东可获收益 (不含非经常性项目) 293.909 236.276 122.385 159.756 126.463
普通股股东可获收益 (含非經常性項目) 293.909 236.276 122.385 159.756 126.463
摊薄净收入 293.909 236.276 122.385 159.756 126.463
摊薄后加权平均股 89.4406 89.4406 89.4406 89.4406 89.4406
扣除特别项目的每股摊薄盈利 3.28608 2.64171 1.36834 1.78617 1.41393
Dividends per Share - Common Stock Primary Issue 1.1 0.9 0.5 0.65 0.55
每股正常摊薄盈利 3.28608 2.62254 1.41621 1.826 1.44229
异常费用(收入) -2.447 0
Other Operating Expenses, Total 1.294 0 -0.015
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
总收入 569.936 477.495 445.229 410.176 448.585
收入 569.936 477.495 445.229 410.176 448.585
收入成本,共计 227.538 193.645 176.654 177.401 180.772
毛利 342.398 283.85 268.575 232.775 267.813
总营业费用 448.957 378.919 342.273 335.808 357.771
销售/一般/行政费用,总计 133.26 111.092 95.837 97.871 111.48
研究与开发 87.165 73.972 69.692 60.536 65.566
异常费用(收入) -0.047
营业收入 120.979 98.576 102.956 74.368 90.814
利息收入(费用),非经营净值 -2.679 -12.957 -8.662 -20.181 -11.82
其他,净值 22.689 2.71 25.805 -0.115 -1.944
税前净收入 140.989 88.329 120.099 54.072 77.05
税后净收入 103.811 61.996 92.095 38.009 54.819
少数股东权益 -1.102 0.536 -1.367 -0.069 -0.743
未计算非常项目前的净收益 102.709 62.532 90.728 37.94 54.076
净收入 102.709 62.532 90.728 37.94 54.076
普通股股东可获收益 (不含非经常性项目) 102.709 62.532 90.728 37.94 54.076
普通股股东可获收益 (含非經常性項目) 102.709 62.532 90.728 37.94 54.076
摊薄净收入 102.709 62.532 90.728 37.94 54.076
摊薄后加权平均股 89.7249 89.3318 89.8297 89.5912 89.8211
扣除特别项目的每股摊薄盈利 1.14471 0.7 1.01 0.42348 0.60204
Dividends per Share - Common Stock Primary Issue 1.1 0 0 0 0.9
每股正常摊薄盈利 1.14471 0.7 1.01 0.42348 0.60167
Other Operating Expenses, Total 0.994 0.21 0.09 0
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 1604.02 1290.51 1304.33 1251.06 1207.89
现金和短期投资 7.439 6.202 22.639 7.843 8.315
Cash 7.439 6.202 22.639 6.678 3.925
现金等价物
应收账款总额,净额 1294.65 979.93 1000.34 981.046 935.904
Accounts Receivable - Trade, Net 185.94 165.158 205.789 192.33 195.256
Total Inventory 286.375 286.36 268.322 248.092 234.303
Prepaid Expenses 9.502 8.144 10.759 9.352 9.986
Other Current Assets, Total 6.049 9.871 2.266 4.723 19.38
Total Assets 2395.97 2014.85 2022.13 1662.05 1623.11
Property/Plant/Equipment, Total - Net 199.555 135.265 116.752 62.632 58.696
Property/Plant/Equipment, Total - Gross 379.88 320.308 280.47 196.305 174.346
Accumulated Depreciation, Total -180.325 -185.043 -163.718 -133.673 -115.65
Goodwill, Net 328.714 326.51 338.094 185.638 174.313
Intangibles, Net 153.698 145.221 144.336 74.087 68.491
Long Term Investments 6.713 4.108 5.173 0.122 19.3
Note Receivable - Long Term 9.191 9.225 10.961 9.29 14.565
Other Long Term Assets, Total 94.079 104.014 102.484 79.227 79.855
Total Current Liabilities 448.118 297.584 339.6 280.18 316.078
Accounts Payable 145.465 91.679 118.12 101.437 100.463
Accrued Expenses 137.816 109.294 115.657 98.181 80.259
Notes Payable/Short Term Debt 0.645 0.209 0.192 15.71 5.733
Current Port. of LT Debt/Capital Leases 19.341 15.512 14.661 3.529 2.819
Other Current Liabilities, Total 144.851 80.89 90.97 61.323 126.804
Total Liabilities 736.641 583.133 623.69 368.588 407.731
Total Long Term Debt 178.425 140.636 151.837 7.321 3.588
Long Term Debt 76.496 87.543 109.009 0 0.593
Capital Lease Obligations 101.929 53.093 42.828 7.321 2.995
Deferred Income Tax 15.438 17.166 18.198 5.234 8.918
Minority Interest 18.056 18.841 18.517 21.17 26.358
Other Liabilities, Total 76.604 108.906 95.538 54.683 52.789
Total Equity 1659.33 1431.72 1398.44 1293.46 1215.38
Common Stock 89.441 89.441 89.441 89.441 89.441
Additional Paid-In Capital 620.137 620.137 620.137 620.137 620.137
Retained Earnings (Accumulated Deficit) 1000.48 808.922 744.673 632.486 555.215
Other Equity, Total -50.729 -86.783 -55.812 -48.6 -49.416
Total Liabilities & Shareholders’ Equity 2395.97 2014.85 2022.13 1662.05 1623.11
Total Common Shares Outstanding 89.4406 89.4406 89.4406 89.4406 89.4406
短期投资 0 1.165 4.39
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 1674.57 1604.02 1451.74
现金和短期投资 21.589 17.918 17.352
现金等价物 8.401 7.439 8.315
短期投资 13.188 10.479 9.037
应收账款总额,净额 1298.01 1274.3 1140.1
Accounts Receivable - Trade, Net 156.475 185.94 164.928
Total Inventory 328.867 286.375 274.078
Other Current Assets, Total 26.105 25.422 20.211
Total Assets 2526.01 2395.97 2217.7
Property/Plant/Equipment, Total - Net 205.703 199.555 189.302
Goodwill, Net 379.934 328.714 323.349
Intangibles, Net 163.484 153.698 144.045
Long Term Investments 6.843 6.713 4.843
Note Receivable - Long Term 9.096 9.191 8.339
Other Long Term Assets, Total 86.374 94.079 96.077
Total Current Liabilities 499.258 448.118 347.866
Accounts Payable 140.474 145.465 123.336
Accrued Expenses 109.277 127.787 92.307
Notes Payable/Short Term Debt 0 0 0
Current Port. of LT Debt/Capital Leases 18.97 19.341 17.876
Other Current Liabilities, Total 230.537 155.525 114.347
Total Liabilities 788.612 736.641 672.152
Total Long Term Debt 189.666 178.425 192.216
Long Term Debt 88.588 76.496 90.194
Capital Lease Obligations 101.078 101.929 102.022
Deferred Income Tax 15.035 15.438 16.932
Minority Interest 18.693 18.056 17.705
Other Liabilities, Total 65.96 76.604 97.433
Total Equity 1737.39 1659.33 1545.55
Common Stock 89.441 89.441 89.441
Additional Paid-In Capital 620.137 620.137 620.137
Retained Earnings (Accumulated Deficit) 1048.65 1000.48 909.534
Other Equity, Total -20.833 -50.729 -73.565
Total Liabilities & Shareholders’ Equity 2526.01 2395.97 2217.7
Total Common Shares Outstanding 89.4406 89.4406 89.4406
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 237.519 123.421 160.579 126.23 135.778
经营活动产生的现金 362.663 178.527 219.634 187.207 37.732
经营活动产生的现金 61.584 60.425 48.37 31.282 24.235
非现金物品 110.074 58.691 76.373 54.526 47.269
Cash Taxes Paid 97.908 58.964 65.07 48.364 54.73
已付现金利息 1.629 1.365 1.903 1.94 1.559
营运资金的变化 -46.514 -64.01 -65.688 -24.831 -169.55
投资活动产生的现金 -75.2 -70.947 -145.846 -28.874 -55.931
资本支出 -66.101 -44.986 -46.711 -34.756 -39.022
其他投资现金流量项目,总计 -9.099 -25.961 -99.135 5.882 -16.909
融资活动产生的现金 -285.889 -122.961 -58.637 -157.237 14.494
融资现金流项目 -223.862 -48.775 4.321 -104.529 -259.854
Total Cash Dividends Paid -44.72 -58.136 -49.192 -49.192 -37.565
债务的发行(退还),净额 -17.307 -16.05 -13.766 -3.516 -3.123
外汇效应 -0.337 -1.056 0.81 1.657 -1.08
现金净变化 1.237 -16.437 15.961 2.753 -4.785
股票的发行(报废),净额 0 315.036
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 130.104 101.501
Cash From Operating Activities 74.484 151.878
Cash From Operating Activities 33.045 29.924
Non-Cash Items 16.671 44.673
Cash Taxes Paid 61.722 41.015
Cash Interest Paid 0.679 0.67
Changes in Working Capital -105.336 -24.22
Cash From Investing Activities -54.311 -28.769
Capital Expenditures -35.335 -23.26
Other Investing Cash Flow Items, Total -18.976 -5.509
Cash From Financing Activities -18.33 -124.663
Financing Cash Flow Items -9.441 -116.396
Issuance (Retirement) of Debt, Net -8.889 -8.267
Foreign Exchange Effects -0.881 -0.31
Net Change in Cash 0.962 2.113
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Carl Zeiss Group Corporation 59.14 52895153 35776 2022-11-15
Capital Research Global Investors Investment Advisor 4.9912 4464153 -46868 2023-02-13 LOW
Capital World Investors Investment Advisor 1.6403 1467117 0 2023-01-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1483 1027089 1286 2023-02-28 LOW
Invesco Advisers, Inc. Investment Advisor 0.8941 799668 -11471 2023-01-31 LOW
Groupama Asset Management Investment Advisor 0.8665 775034 -37628 2022-09-30 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 0.7616 681161 27 2023-02-28 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 0.7572 677231 -8165 2023-02-28 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.7343 656754 -13903 2023-02-28 LOW
Allianz Global Investors GmbH Investment Advisor 0.6845 612201 -1744 2023-02-28 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.5952 532334 153016 2023-02-28 HIGH
Candriam Luxembourg S.A. Investment Advisor 0.5894 527175 -10543 2023-01-31 HIGH
La Financière de l'Echiquier Investment Advisor 0.5405 483394 -6 2022-11-30 LOW
Oddo BHF Asset Management S.A.S Investment Advisor/Hedge Fund 0.4626 413722 -16606 2023-01-31 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.442 395285 17110 2023-02-28 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.4095 366292 -451602 2022-12-31 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 0.332 296921 -10699 2023-02-28 LOW
Credit Mutuel Asset Management Investment Advisor 0.2971 265728 250534 2022-12-31 HIGH
Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund 0.2487 222410 -1214 2022-11-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.2357 210844 1186 2023-01-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Carl Zeiss Meditec Company profile

关于 Carl Zeiss Meditec AG

Carl Zeiss Meditec AG是一家位于德国的医疗技术和设备公司。 它提供诊断和治疗眼科疾病的完整解决方案、显微手术的可视化解决方案和其他技术,如术中放射治疗。 公司的业务分为两个部分。 眼科设备和显微外科。 眼科设备部门包括眼科领域的活动,如眼内镜、手术可视化解决方案和医疗激光及诊断系统。 显微外科部门包括神经、耳鼻喉外科的活动,以及术中辐射领域的活动。 公司在欧洲、美国和亚洲有多个生产基地。

Industry: Advanced Medical Equipment & Technology (NEC)

Göschwitzer Straße 51-52
JENA
THUERINGEN 07745
DE

收入报表

  • Annual
  • Quarterly

人们也观看

US100

12,828.90 Price
-0.040% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

Gold

1,959.48 Price
-0.250% 1D Chg, %
多头隔夜费 -0.0087%
空头隔夜费 0.0005%
隔夜费时间 21:00 (UTC)
价差 0.30

BTC/USD

28,652.45 Price
+0.780% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

XRP/USD

0.53 Price
-3.330% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00408

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易